{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:20:33Z","timestamp":1648506033635},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00393-018-0586-3","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T13:02:50Z","timestamp":1547816570000},"page":"236-242","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infektionen"],"prefix":"10.1007","volume":"78","author":[{"given":"H.-M.","family":"Lorenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kneitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"issue":"11","key":"586_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","volume":"2","author":"G Gavazzi","year":"2002","unstructured":"Gavazzi G, Krause KH (2002) Ageing and infection. Lancet Infect Dis 2(11):659\u2013666 (Nov)","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"586_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/acr.21812","volume":"65","author":"J Widdifield","year":"2013","unstructured":"Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC, Pope J, Cividino A, Bombardier C (2013) Arthritis Care Res 65(3):353\u2013361","journal-title":"Arthritis Care Res"},{"issue":"2","key":"586_CR3","doi-asserted-by":"crossref","first-page":"ofv052","DOI":"10.1093\/ofid\/ofv052","volume":"15;2","author":"AJ Reber","year":"2015","unstructured":"Reber AJ, Kim JH, Biber R, Talbot HK, Coleman LA, Chirkova T, Gross FL, Steward-Clark E, Cao W, Jefferson S, Veguilla V, Gillis E, Meece J, Bai Y, Tatum H, Hancock K, Stevens J, Spencer S, Chen J, Gargiullo P, Braun E, Griffin MR, Sundaram M, Belongia EA, Shay DK, Katz JM, Sambhara S (2015) Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses. Open Forum Infect Dis 15;2(2):ofv52 (Apr)","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"586_CR4","first-page":"68","volume":"3","author":"AJ Reber","year":"2012","unstructured":"Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S (2012) Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population. Aging Dis 3(1):68\u201390 (Epub 2011 Sep 30.)","journal-title":"Aging Dis"},{"issue":"9","key":"586_CR5","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46(9):2294\u20132300 (Sep)","journal-title":"Arthritis Rheum"},{"issue":"2","key":"586_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00393-016-0223-y","volume":"76","author":"B Hellmich","year":"2017","unstructured":"Hellmich B (2017) Current guidelines on ANCA-associated vasculitides: Common features and differences. Z Rheumatol 76(2):133\u2013142","journal-title":"Z. Rheumatol."},{"issue":"5","key":"586_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/annrheumdis-2017-212588","volume":"77","author":"KL Winthrop","year":"2018","unstructured":"Winthrop KL, Baddley JW (2018) Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question. Ann Rheum Dis 77(5):631\u2013633","journal-title":"Ann Rheum Dis"},{"key":"586_CR8","doi-asserted-by":"publisher","first-page":"E000352","DOI":"10.1136\/rmdopen-2016-000352","volume":"3","author":"C Baradat","year":"2017","unstructured":"Baradat C et\u00a0al (2017) RMD Open 3:E352","journal-title":"RMD Open"},{"key":"586_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/1756-185X.12970","volume":"20","author":"H Liao","year":"2017","unstructured":"Liao H et\u00a0al (2017) Comparison of the risk of infections in different anti-TNF agents: a meta-analysis. Int J Rheum Dis 20:161\u2013168","journal-title":"Int J Rheum Dis"},{"key":"586_CR10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1136\/ard.2010.144741","volume":"70","author":"WG Dixon","year":"2011","unstructured":"Dixon WG et\u00a0al (2011) Annals Rheum Dis 70:956\u2013996","journal-title":"Annals Rheum Dis"},{"issue":"7","key":"586_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/rheumatology\/ker146","volume":"50","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Watson KD, Lunt M (2011) BSRBR Control Centre Consortium, Symmons DP; British Society for Rheumatology Biologics Register. The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology 50(7):1341\u20131342","journal-title":"Rheumatology"},{"issue":"6","key":"586_CR12","first-page":"997","volume":"57","author":"AI Rutherford","year":"2018","unstructured":"Rutherford AI, Patarata E, Subesinghe S, Hyrich KL, Galloway JB (2018) Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Baillieres Clin Rheumatol 57(6):997\u20131001","journal-title":"Baillieres Clin Rheumatol"},{"issue":"8","key":"586_CR13","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/art.23112","volume":"57","author":"AL Smitten","year":"2007","unstructured":"Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA (2007) The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 57(8):1431\u20131438 (Dec 15)","journal-title":"Arthritis Rheum"},{"issue":"7","key":"586_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2009.146","volume":"301","author":"A Strangfeld","year":"2009","unstructured":"Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A (2009) Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 301(7):737\u2013744 (Feb 18)","journal-title":"JAMA"},{"key":"586_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.07.006","author":"AJ Kivitz","year":"2018","unstructured":"Kivitz AJ, Cohen S, Keystone E, van Vollenhoven RF, Haraoui B, Kaine J, Fan H, Connell CA, Bananis E, Takiya L, Fleischmann R (2018) A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a\u00a0Phase 3 rheumatoid arthritis population. Semin Arthritis Rheum. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.07.006 (Jul 19. pii: S0049-0172(17)30815-6, Epub ahead of print)","journal-title":"Semin Arthritis Rheum"},{"key":"586_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4199-7","author":"S Kunwar","year":"2018","unstructured":"Kunwar S, Collins CE, Constantinescu F (2018) Baricitinib, a\u00a0Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a\u00a0systematic literature review and meta-analysis of randomized controlled trials. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-018-4199-7 (Jul 13)","journal-title":"Clin Rheumatol"},{"issue":"9","key":"586_CR17","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/acr.21990","volume":"65","author":"N Droz","year":"2013","unstructured":"Droz N, Gilardin L, Cacoub P, Berenbaum F, Wendling D, Godeau B, Piette AM, Dernis E, Ebbo M, Fautrel B, Le Guenno G, Mekinian A, Bernard-Chabert B, Costedoat-Chalumeau N, Descloux E, Michot JM, Radenne S, Rigolet A, Rivi\u00e8re S, Yvin JL, Thibault V, Thabut D, Pol S, Guillevin L, Mouthon L, Terrier B (2013) Kinetic profiles and management of hepatitis B virus reactivation in patients with immune-mediated inflammatory diseases. Arthritis Care Res (hoboken) 65(9):1504\u20131514 (Sep)","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"5","key":"586_CR18","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa1714283","volume":"379","author":"D Menzies","year":"2018","unstructured":"Menzies D, Adjobimey M, Ruslami R, Trajman A, Sow O, Kim H, Obeng Baah J, Marks GB, Long R, Hoeppner V, Elwood K, Al-Jahdali H, Gninafon M, Apriani L, Koesoemadinata RC, Kritski A, Rolla V, Bah B, Camara A, Boakye I, Cook VJ, Goldberg H, Valiquette C, Hornby K, Dion MJ, Li PZ, Hill PC, Schwartzman K, Benedetti A (2018) Four Months of\u00a0Rifampin\u00a0or Nine Months of Isoniazid for Latent Tuberculosis in Adults. N\u00a0Engl J Med 379(5):440\u2013453","journal-title":"N Engl J Med"},{"issue":"2","key":"586_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/1756-185X.12970","volume":"20","author":"H Liao","year":"2017","unstructured":"Liao H, Zhong Z, Liu Z, Zou X (2017) Comparison of the risk of infections in different anti-TNF agents: a\u00a0meta-analysis. Int J Rheum Dis 20(2):161\u2013168","journal-title":"Int J Rheum Dis"},{"key":"586_CR20","first-page":"2097","volume":"14","author":"F Cantini","year":"2017","unstructured":"Cantini F, Nannini C, Niccoli L, Petrone L, Ippolito G, Goletti D (2017) Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics. Ther Clin Risk Manag 14:2097\u20132111","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"586_CR21","first-page":"752","volume":"35","author":"F Bartalesi","year":"2017","unstructured":"Bartalesi F, Scir\u00e8 C, Requena-M\u00e9ndez A et al (2017) Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a\u00a0multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today. Clin Exp Rheumatol 35(5):752\u2013765 (Sep\u2013Oct; Epub\u00a0\u00a02017\u00a0May 8)","journal-title":"Clin Exp Rheumatol"},{"key":"586_CR22","unstructured":"Epidemiologisches Bulletin 34\/2018"},{"issue":"12","key":"586_CR23","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3899\/jrheum.161407","volume":"44","author":"MTT Nguyen","year":"2017","unstructured":"Nguyen MTT, Lindegaard H, Hendricks O, J\u00f8rgensen CS, Kants\u00f8 B, Friis-M\u00f8ller N (2017) Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a\u00a0Randomized Controlled Trial. J\u00a0Rheumatol 44(12):1794\u20131803","journal-title":"J Rheumatol"},{"key":"586_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s13075-015-0863-3","volume":"10;17","author":"K Migita","year":"2015","unstructured":"Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Kozuru H, Jiuchi Y, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Takahi K, Yoshizawa S, Kawabe Y, Suenaga Y, Ozawa T, Hamada N, Komiya Y, Matsui T, Furukawa H, Oishi K (2015) Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients. Arthritis Res Ther 10;17:357 (Dec)","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"586_CR25","first-page":"898","volume":"77","author":"JK Park","year":"2018","unstructured":"Park JK, Lee YJ, Shin K et\u00a0al (2018) Impact of temporary methotrexate discontinuation for 2\u00a0weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a\u00a0randomised clinical trial. Ann Rheum Dis 77(6):898\u2013904","journal-title":"Ann Rheum Dis"},{"key":"586_CR26","unstructured":"Epidemiologisches Bulletin 36\/37 vom 9. Sept. 2013"},{"issue":"6","key":"586_CR27","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s00296-011-1808-z","volume":"32","author":"M Feuchtenberger","year":"2012","unstructured":"Feuchtenberger M, Kleinert S, Schwab S, Roll P, Scharbatke EC, Ostermeier E, Voll RE, Sch\u00e4fer A, Tony HP (2012) Vaccination survey in patients with rheumatoid arthritis: a\u00a0cross-sectional study. Rheumatol Int 32(6):1533\u20131539 (Jun)","journal-title":"Rheumatol Int"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-018-0586-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T22:42:26Z","timestamp":1606084946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-018-0586-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1007\/s00393-018-0586-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]},"assertion":[{"value":"18 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.-M.\u00a0Lorenz und C.\u00a0Kneitz geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}